CHRISTEN KUTZ: Open Payments
NPI 1629138813 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$191,690 in 460 payments from 39 companies in 2025. Trend: 2023 $92,597 · 2024 $108,320 · 2025 $191,690
Speaker / faculty: $105,052Consulting: $55,016Travel & lodging: $15,151Food & beverage: $11,811Honoraria: $4,550Education: $111
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 46 | $67,170 |
| Vanda Pharmaceuticals Inc. | 39 | $28,684 |
| TG Therapeutics, Inc. | 57 | $21,515 |
| Janssen Biotech, Inc. | 32 | $18,219 |
| Alexion Pharmaceuticals, Inc. | 46 | $17,003 |
| Biogen, Inc. | 43 | $16,628 |
| Amgen Inc. | 22 | $9,131 |
| Axsome Therapeutics, Inc. | 11 | $5,835 |
| GENZYME CORPORATION | 10 | $2,039 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $1,725 |
Products named: Mavenclad, PONVORY, BRIUMVI, ULTOMIRIS, VUMERITY, TYSABRI, UPLIZNA, HYQVIA.
Industry payments across CO — which companies pay providers there.
